Clinical Trials Directory

Trials / Completed

CompletedNCT00878475

Dyspnea and Biomarkers in a Prehospital Setting

Quantitative Capnometry and Nt-proBNP in Differentiating of Acute Dyspnea in Pre-Hospital Emergency Setting

Status
Completed
Phase
Study type
Observational
Enrollment
546 (actual)
Sponsor
Community Healthcare Center dr. Adolf Drolc Maribor (HCM) · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In patients presenting with acute dyspnea in a pre-hospital setting, the early and correct diagnosis may present a significant clinical challenge. Physical examination, chest radiography, electrocardiography, and standard biological tests often fail to accurately differentiate heart failure (HF) from pulmonary causes of dyspnea. Timely differentiation of HF from other causes of dyspnea may permit the early institution of appropriate medical therapy. Brain natriuretic peptide (BNP) and amino-terminal pro-brain natriuretic peptide (NT-proBNP) have been proposed as early markers of HF and demonstrated to be useful for diagnosing and excluding HF in the emergency department. A combination of BNP or NT-proBNP testing and standard clinical assessment has been suggested to be superior to either tool used in isolation. Some previous studies have also suggested that quantitative capnometry (QC) may be useful in differentiating between cardiac and obstructive causes of respiratory distress. Therefore, the investigators hypothesized that a new combination of NT-proBNP testing, standard clinical assessment, and partial pressure of end-tidal CO2 (PetCO2) would optimize evaluation and differentiation of acute dyspnea in a pre-hospital setting. The aim of this study was to determine the accuracy of combination of QC, NT-proBNP, and clinical assessment in differentiating acute HF from obstructive pulmonary disease (COPD/asthma) as a cause of acute dyspnea in pre-hospital emergency setting.

Conditions

Timeline

Start date
2005-01-01
Primary completion
2007-06-01
Completion
2007-06-01
First posted
2009-04-09
Last updated
2009-04-09

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT00878475. Inclusion in this directory is not an endorsement.